GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Par Drugs and Chemicals Ltd (NSE:PAR) » Definitions » Asset Turnover

Par Drugs and Chemicals (NSE:PAR) Asset Turnover : 0.30 (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Par Drugs and Chemicals Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Par Drugs and Chemicals's Revenue for the three months ended in Sep. 2024 was ₹347 Mil. Par Drugs and Chemicals's Total Assets for the quarter that ended in Sep. 2024 was ₹1,157 Mil. Therefore, Par Drugs and Chemicals's Asset Turnover for the quarter that ended in Sep. 2024 was 0.30.

Asset Turnover is linked to ROE % through Du Pont Formula. Par Drugs and Chemicals's annualized ROE % for the quarter that ended in Sep. 2024 was 35.53%. It is also linked to ROA % through Du Pont Formula. Par Drugs and Chemicals's annualized ROA % for the quarter that ended in Sep. 2024 was 29.73%.


Par Drugs and Chemicals Asset Turnover Historical Data

The historical data trend for Par Drugs and Chemicals's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Par Drugs and Chemicals Asset Turnover Chart

Par Drugs and Chemicals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Asset Turnover
Get a 7-Day Free Trial 0.99 0.88 0.96 1.14 1.00

Par Drugs and Chemicals Quarterly Data
Mar19 Sep19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.25 0.22 0.22 0.30

Competitive Comparison of Par Drugs and Chemicals's Asset Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Par Drugs and Chemicals's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Par Drugs and Chemicals's Asset Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Par Drugs and Chemicals's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Par Drugs and Chemicals's Asset Turnover falls into.



Par Drugs and Chemicals Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Par Drugs and Chemicals's Asset Turnover for the fiscal year that ended in Mar. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=951.065/( (888.679+1016.111)/ 2 )
=951.065/952.395
=1.00

Par Drugs and Chemicals's Asset Turnover for the quarter that ended in Sep. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=346.569/( (0+1156.549)/ 1 )
=346.569/1156.549
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Par Drugs and Chemicals  (NSE:PAR) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Par Drugs and Chemicals's annulized ROE % for the quarter that ended in Sep. 2024 is

ROE %**(Q: Sep. 2024 )
=Net Income/Total Stockholders Equity
=343.832/967.609
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(343.832 / 1386.276)*(1386.276 / 1156.549)*(1156.549/ 967.609)
=Net Margin %*Asset Turnover*Equity Multiplier
=24.8 %*1.1986*1.1953
=ROA %*Equity Multiplier
=29.73 %*1.1953
=35.53 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Par Drugs and Chemicals's annulized ROA % for the quarter that ended in Sep. 2024 is

ROA %(Q: Sep. 2024 )
=Net Income/Total Assets
=343.832/1156.549
=(Net Income / Revenue)*(Revenue / Total Assets)
=(343.832 / 1386.276)*(1386.276 / 1156.549)
=Net Margin %*Asset Turnover
=24.8 %*1.1986
=29.73 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Par Drugs and Chemicals Asset Turnover Related Terms

Thank you for viewing the detailed overview of Par Drugs and Chemicals's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Par Drugs and Chemicals Business Description

Traded in Other Exchanges
N/A
Address
Gotri Vasna Road, 816, Nilamber Triumph, Vadodara, GJ, IND, 390007
Par Drugs and Chemicals Ltd is engaged in the development and manufacture of Active Pharma Ingredients (APIs) for the domestic market as well as for exports to international markets. APIs are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage. The company is dealing in only one segment i.e. manufacturing industry, API.